从未迷惑 发表于 2025-3-21 19:27:19

书目名称Cancer Policy: Pharmaceutical Safety影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0221175<br><br>        <br><br>书目名称Cancer Policy: Pharmaceutical Safety读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0221175<br><br>        <br><br>

赏钱 发表于 2025-3-21 22:04:35

New Documentaries in Latin AmericaThis Chapter provides an introduction and overview of the U.S. FDA REMS program and applicable regulatory aspects. Topics covered include the 2015 Draft Guidance, organization structure and functions, a discussion on pharmacovigilance and adverse event reports, and a discussion of the applicability of REMS in oncology.

交响乐 发表于 2025-3-22 02:48:32

http://reply.papertrans.cn/23/2212/221175/221175_3.png

特征 发表于 2025-3-22 06:56:07

http://reply.papertrans.cn/23/2212/221175/221175_4.png

NICHE 发表于 2025-3-22 12:40:46

http://reply.papertrans.cn/23/2212/221175/221175_5.png

BIPED 发表于 2025-3-22 15:31:14

June M. McKoy,Dennis P. WestDescribes the latest thoughts and findings relating to drug safety in the cancer domain.Covers emerging strategies to identify adverse drug reactions and drug-drug interactions.Highlights policies ins

BIPED 发表于 2025-3-22 17:33:24

http://reply.papertrans.cn/23/2212/221175/221175_7.png

paleolithic 发表于 2025-3-22 22:04:25

http://reply.papertrans.cn/23/2212/221175/221175_8.png

engender 发表于 2025-3-23 02:47:42

Essay 2: Environmental Performance,ic concerns drive drug safety improvements. This chapter examines pressures on drug costs due to the complexity of care and drug therapies, marked structure in which care is provided, and regulatory requirements driving safety.

ineffectual 发表于 2025-3-23 07:53:04

http://reply.papertrans.cn/23/2212/221175/221175_10.png
页: [1] 2 3 4 5
查看完整版本: Titlebook: Cancer Policy: Pharmaceutical Safety; June M. McKoy,Dennis P. West Book 2019 Springer Nature Switzerland AG 2019 Drug Safety.Health.Oncolo